Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults

Lactobacillus johnsonii N6.2 mitigates the onset of type 1 diabetes (T1D) in biobreeding diabetes-prone rats, in part, through changes in kynurenine:tryptophan (K:T) ratios. The goal of this pilot study was to determine the safety, tolerance, and general immunological response of L. johnsonii N6.2 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcial, Guillermo E., Ford, Amanda L., Haller, Michael J., Gezan, Salvador A., Harrison, Natalie A., Cai, Dan, Meyer, Julie L., Perry, Daniel J., Atkinson, Mark A., Wasserfall, Clive H., Garrett, Timothy, Gonzalez, Claudio F., Brusko, Todd M., Dahl, Wendy J., Lorca, Graciela L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466969/
https://www.ncbi.nlm.nih.gov/pubmed/28659913
http://dx.doi.org/10.3389/fimmu.2017.00655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466969/
https://www.ncbi.nlm.nih.gov/pubmed/28659913
http://dx.doi.org/10.3389/fimmu.2017.00655

Ejemplares similares